Coll et al. demonstrate that MCC950 does not block the major anti-microbial inflammasomes NLRC4 and NLRP1, which means it will not completely block IL-1β and antimicrobial responses may remain intact during infection [11]. This evidence concerns the gene NLRC4 and infection.